Short-Chain Fatty Acids Play Crucial Role in Regulating T Lymphocyte Function

Strategic Insights -

Recent research at Middle East University in Amman, Jordan, has elucidated the multifunctional role of short-chain fatty acids (SCFAs) in T lymphocyte biology, highlighting their therapeutic potential in cancer, infection, and autoimmune diseases. SCFAs, including acetate, propionate, and butyrate, have significant functions in host immune modulation, particularly in regulating T-cell growth, differentiation, metabolism, effector function, and apoptosis.

Key Takeaways:

  • Short-chain fatty acids (SCFAs) are microbial metabolites that play a crucial role in regulating T lymphocyte function, with implications for autoimmune diseases and cancer.
  • SCFAs regulate T-cell growth, differentiation, metabolism, effector function, and apoptosis through histone deacetylase (HDAC) inhibition, G-protein-coupled receptor (GPCR) signaling, and metabolic reprogramming processes.
  • Butyrate enhances regulatory T cell (Treg) and Interleukin 10 (IL-10)-producing T helper 1 (Th1) cell differentiation, as well as context-dependent regulation on T helper 17 (Th17) cell development.
  • SCFAs impact cytotoxic CD8+ T cells through augmented production of IFN-g and memory formation, enhancing antiviral and antitumor immunity.
  • SCFAs reprogram T-cell metabolism through enhanced acetyl-CoA, mechanistic target of rapamycin (mTOR) signaling, and fatty acid oxidation (FAO), promoting the unique metabolic requirements of effector and memory T-cell subsets.
  • SCFAs induce apoptosis of activated T cells through the Fas upregulation by inhibiting HDAC1.
  • SCFA dysregulation plays a role in disease and autoimmune disorders, such as type 1 diabetes and rheumatoid arthritis, whereas therapeutic supplementation reduces inflammation and immune tolerance.
  • SCFAs amplify the antitumor effect of immune checkpoint inhibitors (e.g., anti-programmed cell death protein 1 (anti-PD-1)) in cancer by driving CD8+ T-cell activation, infiltration, and Interferon gamma (IFNg) production, partially through the transcriptional regulator Inhibitor of DNA binding 2 (ID2).

Statistics:

  • 2025: The year the research was conducted and peer-reviewed.
  • 52(5): Journal volume and issue number where the research was published.
  • 152398: The article's unique identifier in the journal.
  • 1600 John F Kennedy Boulevard: Address of W B Saunders Co-elsevier Inc, the publisher of the journal.
  • 19103-2899: Zip code of W B Saunders Co-elsevier Inc.
  • 11831: Zip code of Middle East University, the institution where the research was conducted.

Sources:

  • NewsRx. Recent Findings from Middle East University Provide New Insights into Autoimmunity (The effects of microbiota-derived short-chain fatty acids on T lymphocytes: From autoimmune diseases to cancer). Cancer Weekly. September 16, 2025; p 4281.
  • Seminars In Oncology. The effects of microbiota-derived short-chain fatty acids on T lymphocytes: From autoimmune diseases to cancer. Seminars In Oncology, 2025;52(5):152398.
  • Elsevier. www.elsevier.com
  • Seminars In Oncology. www.journals.elsevier.com/seminars-in-oncology/
  • Faculty of Pharmacy, Middle East University, Amman, 11831, Jordan
  • W B Saunders Co-elsevier Inc, 1600 John F Kennedy Boulevard, Ste 1800, Philadelphia, PA 19103-2899, USA